CONTINGENT CONSIDERATION AND INTANGIBLE ASSET (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Feb. 25, 2025 |
Mar. 31, 2026 |
Oct. 20, 2025 |
|
| Ciro Leonardo Pierri [Member] | Maximum [Member] | |||
| Maximum amount payable | $ 1,600 | ||
| MitoCareX Bio Ltd [Member] | |||
| Business Combination, Consideration Transferred, Equity Interest | $ 393 | ||
| Cash consideration | 536 | ||
| Contingent consideration | $ 863 | ||
| MitoCareX Bio Ltd [Member] | Ciro Leonardo Pierri [Member] | |||
| Ownership percentage | 30.00% | ||
| MitoCareX Bio Ltd [Member] | |||
| Subsidiary, ownership percentage, parent | 25.00% |
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition Amount of long-term notes payable classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|